Category: Congress Info

Jean-Paul Pirnay Wins Best Scientific Contribution at Phage Therapy 2024

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Best Scientific Contribution award was discerned to: Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium Dr. Pirnay, an active scientific board member, concluded the conference and presented an insightful presentation titled “Magistral Phage Preparations – Is This the Model for Everyone?” In his presentation, Dr. Pirnay explored: 🔹 Phage therapy as…
Posted on June 26, 2024
Read More

Engineered M13 Bacteriophage for Cancer Therapy Wins Best Short Oral at Phage Therapy 2024

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Best Short Oral Presentation award (2) was discerned to: Nanobiotechnological Engineering of the M13 Bacteriophage for Targeted Photodynamic Cancer Therapy Alena Kaltenbrunner, University of Bologna, Italy Her study developed recombinant M13 phages displaying nanobodies specific to cancer markers EGFR and Her2, and conjugated with photosensitizers. These engineered phages demonstrated high…
Posted on June 26, 2024
Read More

Immune Response to Nebulized Phage Therapy in Cystic Fibrosis Patients Wins Best Short Oral at Phage Therapy 2024

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Best Short Oral Presentation award was discerned to: Neutralizing Antibodies After Nebulized Phage Therapy in Cystic Fibrosis Patients Marco Pardo-Freire, University of Valencia, Spain His research demonstrated that nebulized phage therapy significantly reduces bacterial load in Cystic Fibrosis (CF) patients with lung infections and highlighted the emergence of phage-neutralizing antibodies,…
Posted on June 26, 2024
Read More

Phage-Based Tool for Treating Antibiotic-Resistant Gonorrhea Wins Best Poster at Phage Therapy 2024

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Best Poster Presentation award was discerned to: Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland Ms. Pelka’s research focused on developing a phage-based tool to treat antibiotic-resistant gonorrhea. Her work involves isolating and characterizing phages with lytic activity against Neisseria gonorrhoeae,…
Posted on June 26, 2024
Read More

Abstracts Book of Targeting Phage Therapy 2024 is Now Available

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Abstract Book has been released.  You can now gain access to the abstracts of 40 communications, featuring major talks, short orals, and posters, highlighting advancements in phage therapy. Phage Therapy 2024 Communications You can learn more about the communications in the conference program: www.phagetherapy-site.com/Program. How to Access Abstracts Book Order…
Posted on June 11, 2024
Read More
Advances in Phage Therapy and Antimicrobial Strategies: Insights from Oral Presentations 2024

Advances in Phage Therapy and Antimicrobial Strategies: Insights from Oral Presentations 2024

Posted on by Targeting Phage Therapy
The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. The recent collection of oral presentations provides a comprehensive overview of the latest advancements in phage therapy and antimicrobial research. Oral Presentation Summaries and…
Posted on June 10, 2024
Read More
DOI Allocation for Targeting Phage Therapy 2024 Abstracts

DOI Allocation for Targeting Phage Therapy 2024 Abstracts

Posted on by Targeting Phage Therapy
It is a great pleasure to announce that all abstracts submitted to the 7th World Conference on Targeting Phage Therapy will be included in the Abstracts Book 2024, assigned with a DOI (Digital Object Identifier). Why a DOI? A DOI ensures that your abstracts are indexed on major academic platforms such as ORCID, Google Scholar,…
Posted on June 5, 2024
Read More
Selected Poster Presentation – Targeting Phage Therapy 2024

Selected Poster Presentation – Targeting Phage Therapy 2024

Posted on by Targeting Phage Therapy
The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. Poster Summaries and Scientific Impacts 1. Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland The…
Posted on June 4, 2024
Read More
Meet the Industries Attending Targeting Phage Therapy 2024

Meet the Industries Attending Targeting Phage Therapy 2024

Posted on by Targeting Phage Therapy
Targeting Phage Therapy 2024 gathered 15+ key players in the phage therapy industry to showcase. Participants engaged in meaningful discussions on the latest research, regulatory landscapes, and successful case studies in phage therapy.  Attendees had the opportunity to learn about advancements in phage selection, manufacturing, and production, which are crucial for the development and implementation…
Posted on June 4, 2024
Read More

Dr. Schooley’s call to action: Elevating phage therapy trials through strategic translational research

Posted on by Targeting Phage Therapy
The 7th World Conference on Targeting Phage Therapy was organized on June 20-21, 2024 at Corinthia Palace Malta. Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, and Co-Director of the Center for Innovative Phage Applications and Therapeutics and member of the Executive Committee for the University of California Disaster…
Posted on March 13, 2024
Read More